Rosiglitazone improves outcomes for patients with impaired glucose

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1556, 2006-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjunctive rosiglitazone significantly improves glycaemic control in patients with type 2 diabetes

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

HAART improves outcomes in patients with HIV-related HD

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Impaired Glucose Metabolism in Patients with Heart Failure: Pathophysiology and Possible Treatment Strategies

By Alexander Tenenbaum Enrique Z. Fisman

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 269-280

Adis International

Access to resources Recommend Favorite

Potential of -Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose Tolerance

By Rabasa-Lhoret R. Chiasson L.

Drugs & Aging, Vol. 13, Iss. 2, 1998-08 ,pp. : 131-143

Adis International

Access to resources Recommend Favorite

A fixed combination of rosiglitazone plus metformin improves glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM)

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite